Science and innovation

Explore the latest news from Etap-LAB

Contact an expert

Published on the 5 October 2016

NEW RATING SCALE OF AIMs IN OUR L-DOPA INDUCED DYSKINESIAS RAT MODEL

L-DOPA remains the most effective therapy in the management of the motor symptoms of Parkinson's disease (PD). However, chronic treatment with levodopa is associated with the risk of development of mo…

Science and innovation
Published on the 27 September 2016

Poster presentation at the 4th World Congress on Targeting Microbiota

DERMATOLOGY : ETAP-Lab's preclinical results obtained for PiLeJe will be presented in a poster “Identification of two probiotic strains able to prevent skin inflammation in a murine mo…

Science and innovation Events
Published on the 29 August 2016

ETAP-Lab associates with MIRCen to perform a MRI translationnal study in stroke

ETAP-Lab is pleased to announce a 12-month collaboration with the MIRCen imaging platform directed by Pr. Philippe Hantraye(French Atomic Energy Commission (CEA), Fontenay-aux-Rose…

Science and innovation
Published on the 21 July 2016

From preclinic to clinic: CEN Nutriment and ETAP-Lab new partnership for a global offer to health-nutrition R&D

CEN Nutriment and ETAP-Lab are pleased to announce they go into partnership to propose a global advice and service offer aimed at allowing their clients to meet EFSA requirement regarding scienti…

Science and innovation
Published on the 18 July 2016

New article co-written by ETAP-Lab published in Journal of Medicinal Food.

Publication of a new article co-written by ETAP-Lab in the field of Visceral Pain: “Benefits of preventive administration of Chlorella sp. on visceral pain and cystitis induced by a single a…

Science and innovation
Published on the 15 April 2016

New article co-written by ETAP-Lab accepted by Journal of Medicinal Food

A new article co-written by ETAP-Lab in the field of Visceral Pain and entitled “Benefits of preventive administration of Chlorella sp. on visceral pain and cystitis induced by a single admi…

Science and innovation
Published on the 31 March 2016

Immunization therapies, synuclein and Parkinson’s disease – multiple system atrophy

Vaccination is increasingly being investigated as a potential treatment for synucleinopathies, a group of neurodegenerative diseases including Parkinson's disease, multiple system atrophy, and dementi…

Science and innovation
Published on the 22 March 2016

Synucleopathies and preclinical Parkinson disease models

Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies, have all something in common. They all belong to a group of neurodegenerative diseases called synucleinopathies, including p…

Science and innovation

Explore our scientific resources and browse posters…

Explore Our Resources